• Something wrong with this record ?

Clostridioides difficile epidemiology in the Middle and the Far East

M. Brajerova, J. Zikova, M. Krutova

. 2022 ; 74 (-) : 102542. [pub] 20220228

Language English Country Great Britain

Document type Journal Article, Meta-Analysis, Review

OBJECTIVES: Clostridioides difficile is an important pathogen of healthcare-associated gastrointestinal infections. Recently, an increased number of C. difficile infection (CDI) surveillance data has been reported from Asia. The aim of this review is to summarize the data on the prevalence, distribution and molecular epidemiology of CDI in the Middle and the Far East. METHODS: Literature was drawn from a search of PubMed up to September 30, 2021. RESULTS: The meta-analysis of data from 111 studies revealed the pooled CDI prevalence rate in the Middle and the Far East of 12.4% (95% CI 11.4-13.3); 48 studies used PCR for CDI laboratory diagnoses. The predominant types (RT)/sequence type (ST) differ between individual countries (24 studies, 14 countries). Frequently found RTs were 001, 002, 012, 017, 018 and 126; RT017 was predominant in the Far East. The epidemic RT027 was detected in 8 countries (22 studies), but its predominance was reported only in three studies (Israel and Iran). The contamination of vegetable and meat or meat products and/or intestinal carriage of C. difficile in food and companion animals have been reported; the C. difficile RTs/STs identified overlapped with those identified in humans. CONCLUSIONS: A large number of studies on CDI prevalence in humans from the Middle and the Far East have been published; countries with no available data were identified. The number of studies on C. difficile from non-human sources is limited. Comparative genomic studies of isolates from different sources are needed.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018898
003      
CZ-PrNML
005      
20220804135153.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.anaerobe.2022.102542 $2 doi
035    __
$a (PubMed)35240336
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Brajerova, Marie $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Czech Republic
245    10
$a Clostridioides difficile epidemiology in the Middle and the Far East / $c M. Brajerova, J. Zikova, M. Krutova
520    9_
$a OBJECTIVES: Clostridioides difficile is an important pathogen of healthcare-associated gastrointestinal infections. Recently, an increased number of C. difficile infection (CDI) surveillance data has been reported from Asia. The aim of this review is to summarize the data on the prevalence, distribution and molecular epidemiology of CDI in the Middle and the Far East. METHODS: Literature was drawn from a search of PubMed up to September 30, 2021. RESULTS: The meta-analysis of data from 111 studies revealed the pooled CDI prevalence rate in the Middle and the Far East of 12.4% (95% CI 11.4-13.3); 48 studies used PCR for CDI laboratory diagnoses. The predominant types (RT)/sequence type (ST) differ between individual countries (24 studies, 14 countries). Frequently found RTs were 001, 002, 012, 017, 018 and 126; RT017 was predominant in the Far East. The epidemic RT027 was detected in 8 countries (22 studies), but its predominance was reported only in three studies (Israel and Iran). The contamination of vegetable and meat or meat products and/or intestinal carriage of C. difficile in food and companion animals have been reported; the C. difficile RTs/STs identified overlapped with those identified in humans. CONCLUSIONS: A large number of studies on CDI prevalence in humans from the Middle and the Far East have been published; countries with no available data were identified. The number of studies on C. difficile from non-human sources is limited. Comparative genomic studies of isolates from different sources are needed.
650    _2
$a antibakteriální látky $x terapeutické užití $7 D000900
650    _2
$a Clostridioides $7 D000082682
650    12
$a Clostridioides difficile $x genetika $7 D016360
650    12
$a klostridiové infekce $x farmakoterapie $x epidemiologie $7 D003015
650    12
$a infekce spojené se zdravotní péčí $x epidemiologie $7 D003428
650    _2
$a lidé $7 D006801
650    _2
$a ribotypizace $7 D021521
651    _2
$a Dálný východ $7 D005202
655    _2
$a časopisecké články $7 D016428
655    _2
$a metaanalýza $7 D017418
655    _2
$a přehledy $7 D016454
700    1_
$a Zikova, Jaroslava $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Czech Republic; Department of Genetics and Microbiology, Faculty of Science, Charles University, Czech Republic
700    1_
$a Krutova, Marcela $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Czech Republic. Electronic address: marcela.krutova@lfmotol.cuni.cz
773    0_
$w MED00006567 $t Anaerobe $x 1095-8274 $g Roč. 74, č. - (2022), s. 102542
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35240336 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135146 $b ABA008
999    __
$a ok $b bmc $g 1822473 $s 1170141
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 74 $c - $d 102542 $e 20220228 $i 1095-8274 $m Anaerobe $n Anaerobe $x MED00006567
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...